GlaxoSmithKline (Australia)
Parent institution GlaxoSmithKline (United Kingdom)
ROR: Yes
Works count: 149
Citations count: 5,876
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
2012 · Gerald S. Falchook, Georgina V. Long, et al. · The Lancet
Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia
2004 · Silvia Amadesi, Jingjiang Nie, et al. · Journal of Neuroscience
A Papaver somniferum 10-Gene Cluster for Synthesis of the Anticancer Alkaloid Noscapine
2012 · Thilo Winzer, Valeria E. Gazda, et al. · Science